FEBS Letters · 2002 · 82 citations · 49 references
Life SciencesCell BiologyOncologyApoptosisMolecular OncologySignal TransductionApoptosis In CancerApoptotic SignalingBcl-2 Family ProteinsCancer Cell SignalingHormone-related CarcinogenesisProstate CancerApoptosis Regulation By KinasesBcl-2 Protein ExpressionEstrogen MetabolitesEstrogen ReceptorsHormonal Carcinogenesis
Prostate and breast carcinomas are sex hormone-related carcinomas, which are known to be associated with an over-expression of the proto-oncogene Bcl-2. Here, we report that 2-methoxyestradiol (2-ME), an endogenous metabolite of estrogen that does not bind to nuclear estrogen receptors, effectively induces apoptosis in Bcl-2-expressing human prostate and breast carcinoma cells in vitro and in a rat prostate tumor model in vivo. In several cell lines derived from prostate, breast, liver and colorectal carcinomas, 2-ME treatment led to an activation of c-Jun N-terminal kinase (JNK) and phosphorylation of Bcl-2, which preceded the induction of apoptosis. In summary, our data suggest that 2-ME induces apoptosis in epithelial carcinomas by causing phosphorylation of JNK, which appears to be correlated with phosphorylation of Bcl-2.
49
Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis
Zhengui Xia, Martin Dickens, Joël Raingeaud et al. · Science · 1995 · 5.3K citations
Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
David M. Hockenbery, Gabriel Núñez, Curt Milliman et al. · Nature · 1990 · 3.8K citations
Transplacental Carcinogenesis by Stilbestrol
Judah Folkman · New England Journal of Medicine · 1971 · 2.6K citations
Pharmacy, Oncology, Toxicology +17
The stress-activated protein kinase subfamily of c-Jun kinases
John Kyriakis, Papia T. Banerjee, Eleni Nikolakaki et al. · Nature · 1994 · 2.6K citations